Daniel C. Cattran - Publications

Proteinuria remission and long-term kidney outcome in children with IgA nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: July 11, 2026

A secondary analysis of the TESTING trial predicted individual patient response to corticosteroid treatment in IgA nephropathy.

Journal: Kidney international

Published: August 29, 2025

Erratum to "Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts" [Kidney International Reports Volume 10, Issue 4, April 2025, Pages 1283-1287].

Journal: Kidney international reports

Published: July 18, 2025

Long-term Outcome of Adult Patients With Membranous Nephropathy Treated With Rituximab.

Journal: Kidney international reports

Published: February 28, 2025

Predictive Value of the Oxford Classification for the Effect of Glucocorticoid Therapy in IgA Nephropathy.

Journal: Journal of the American Society of Nephrology : JASN

Published: January 25, 2025

Using the International IgA Nephropathy Prediction Tool to Enrich Clinical Trial Cohorts.

Journal: Kidney international reports

Published: November 28, 2024

Predicting Remission in Antiphospholipase A2 Receptor Antibody-Associated Membranous Nephropathy: A Secondary Analysis of the GEMRITUX, MENTOR, and STARMEN Trials.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: November 06, 2024

Rituximab or cyclosporine A for the treatment of membranous nephropathy: economic evaluation of the MENTOR trial.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: January 29, 2024

Application of the updated International IgA Nephropathy Prediction Tool in children one or two years post-biopsy.

Journal: Kidney international

Published: December 13, 2023

Phase 2 Trial of Cemdisiran in Adult Patients with IgA Nephropathy: A Randomized Controlled Trial.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: July 27, 2023

Evaluating Progression Risk in Patients With Immunoglobulin A Nephropathy.

Journal: Kidney international reports

Published: June 06, 2023

Focal Segmental Glomerulosclerosis: Assessing the Risk of Relapse.

Journal: Kidney international reports

Published: May 22, 2023